Viagra (Sildenafil): How to Safely Stop Taking It

What Sildenafil Does in the Body

Sildenafil works by selectively blocking PDE5, the enzyme that degrades cyclic GMP (cGMP) in penile smooth muscle. When sexual stimulation triggers nitric oxide release, cGMP accumulates, smooth muscle relaxes, arterial inflow increases, and an erection follows. By slowing cGMP breakdown, sildenafil amplifies a signal that must already be present; it does not generate arousal on its own. Goldstein et al. Established this mechanism in a landmark 1998 NEJM randomized controlled trial enrolling 532 men with erectile dysfunction of organic, psychogenic, or mixed etiology.

PDE5 Selectivity and Systemic Effects

Sildenafil is roughly 10-fold more selective for PDE5 than for PDE6 (found in retinal photoreceptors), which explains the transient blue-tinge visual disturbance reported by a minority of users at the 100 mg dose. PDE1, expressed in cardiac and vascular smooth muscle, is inhibited only at concentrations far above therapeutic levels. The FDA prescribing information for sildenafil confirms this selectivity profile and lists the resulting cardiovascular effects, including modest systemic vasodilation and a mean 8.4 mmHg drop in systolic blood pressure.

Pharmacokinetics: Why the Drug Clears Quickly

The mean plasma half-life of sildenafil is 3 to 5 hours. N-desmethyl sildenafil, its primary metabolite, retains about 50% of the parent drug's PDE5 potency and contributes to the 4 to 6 hour window of effect. After a single 50 mg dose in a fasting man, peak plasma concentration is reached at roughly 60 minutes. Because the drug clears within one day, there is no accumulating depot that needs gradual reduction when stopping.

On-Demand vs. Daily Dosing Regimens

Most prescriptions are written for on-demand use. A lower daily dose of 25 mg is sometimes prescribed for men who have sexual activity more than twice weekly or who benefit from continuous PDE5 inhibition for lower urinary tract symptoms associated with benign prostatic hyperplasia. A 2014 meta-analysis in the European Urology journal (PMID 24412149, N=5,222 patients across 12 RCTs) found that daily tadalafil, a longer-acting PDE5 inhibitor, significantly improved both International Prostate Symptom Scores and erectile function vs. Placebo. The same BPH rationale applies to daily sildenafil for some patients, and that indication affects how a clinician thinks about stopping.

Does Sildenafil Cause Dependence or Withdrawal?

No. Sildenafil does not act on opioid receptors, dopaminergic reward pathways, or GABAergic inhibitory circuits. These are the systems whose disruption produces the physiological withdrawal syndromes associated with opioids, benzodiazepines, and alcohol. The FDA scheduling database classifies sildenafil as a non-controlled prescription drug, with no abuse potential rating under the Controlled Substances Act.

Psychological Reliance Is Different from Physical Dependence

Some men develop strong confidence in their erections when using sildenafil and feel anxious about sexual performance after stopping. This is psychological reliance, not a pharmacological dependence state. The anxiety itself can provoke erectile difficulty through sympathetic nervous system activation, which may feel like a "withdrawal" effect but is not driven by any pharmacokinetic rebound. Cognitive behavioral therapy and sex therapy have evidence for addressing performance anxiety directly. A 2021 systematic review in Sexual Medicine Reviews (PMID 33051195) found that psychosexual interventions improved erectile function scores independent of PDE5 inhibitor use.

Rebound Erectile Dysfunction: Is It Real?

A subset of men report worsening erections in the weeks after stopping sildenafil. The available evidence suggests this reflects the natural course of the underlying vascular or hormonal condition rather than a drug-withdrawal effect. Because sildenafil does not alter baseline nitric oxide synthase expression or endothelial function in a lasting way after standard on-demand use, removal of the drug simply returns the patient to his baseline erectile capacity. A 2016 review in the Journal of Sexual Medicine (PMID 27498199) confirmed that PDE5 inhibitors do not durably alter endogenous nitric oxide production.

How to Stop Sildenafil Safely: A Step-by-Step Clinical Approach

Stopping sildenafil does not require a pharmacological taper. The protocol below focuses on the clinical steps a prescriber and patient should take to ensure the underlying condition is addressed and the transition off the drug is medically sound.

Step 1. Identify Why You Are Stopping

The reason for discontinuation shapes everything else. Common reasons include:

• Side effects (headache, flushing, visual changes, priapism, severe hypotension)
• New contraindication (starting a nitrate for cardiac disease, starting an alpha-blocker at a dose that produces symptomatic hypotension)
• Successful treatment of the root cause (testosterone replacement therapy correcting hypogonadal ED, revascularization, lifestyle-driven improvement)
• Planned transition to a different PDE5 inhibitor such as tadalafil 5 mg daily or vardenafil
• Patient preference (relationship changes, reduced sexual activity)

Each reason carries a different follow-up plan. A man stopping because he began a nitrate needs immediate guidance: the FDA label states that sildenafil is absolutely contraindicated with organic nitrates in any form because combined use can produce severe, potentially fatal hypotension. Stopping sildenafil resolves that drug interaction within 24 hours given its half-life.

Step 2. Address the Underlying Condition

Erectile dysfunction is a vascular symptom at least as often as it is a psychogenic one. A 2018 analysis in the Journal of the American College of Cardiology (PMID 30309477) found that new-onset ED preceded a major adverse cardiac event by a mean of 2 to 5 years in men under age 60, establishing ED as an independent cardiovascular risk marker. Stopping sildenafil without evaluating and treating the underlying etiology leaves a cardiovascular signal unaddressed.

Relevant workup before final discontinuation may include:

• Fasting lipid panel, HbA1c, blood pressure measurement
• Total and free testosterone, LH, prolactin if hypogonadism is suspected
• Penile Doppler ultrasound if vascular insufficiency is suspected
• Psychosexual history if performance anxiety is prominent

Step 3. Taper Only When Daily Dosing Has Been Used Long-Term

For on-demand users, no dose reduction is needed. Stop the drug and the pharmacological effect is gone within one day. For men who have been taking sildenafil 25 mg daily for months to years (for BPH or continuous ED management), a brief step-down over two to four weeks is a reasonable clinical practice. This gives time to observe any symptomatic return before the drug fully clears psychologically, rather than for any pharmacokinetic reason.

A practical two-step reduction for daily users:

| Week | Dose | Notes | |------|------|-------| | 1 to 2 | 25 mg every other day | Maintain sexual activity log | | 3 to 4 | 25 mg twice weekly | Assess IIEF-5 score at week 4 | | After week 4 | Discontinue | Follow-up with prescriber within 30 days |

This schedule has no RCT evidence behind it; it is a clinician consensus approach for managing patient expectations, not for preventing a physiological syndrome.

Step 4. Manage the Psychological Transition

Set clear expectations before the final dose. Men who understand that sildenafil amplifies existing arousal (rather than creating erections independently) tend to have less anxiety about stopping. Discuss that some trial periods without the drug are appropriate to re-establish baseline function, particularly if the root cause has been treated.

The American Urological Association 2018 guideline on ED (available at auanet.org and indexed on PubMed PMID 29888060) recommends shared decision-making around PDE5 inhibitor use, including explicit discussion of discontinuation goals when initiating therapy.

Step 5. Schedule a Follow-Up

A follow-up visit at 4 to 8 weeks after stopping allows the clinician to:

• Score erectile function with the validated IIEF-5 questionnaire (score range 5 to 25; scores below 21 indicate some degree of ED)
• Reassess cardiovascular risk factors
• Decide whether re-initiation, a different PDE5 inhibitor, or a non-pharmacological approach is appropriate

Side Effects That Warrant Stopping Immediately

Not all discontinuations are elective. Stop sildenafil and seek same-day medical care for:

• Priapism (erection lasting more than 4 hours): a urological emergency. Ischemic priapism causes irreversible corporal fibrosis if not treated within 4 to 6 hours, per the AUA Priapism Guideline (PMID 12607921).
• Sudden vision or hearing loss: post-marketing reports linked sildenafil to non-arteritic anterior ischemic optic neuropathy (NAION); the FDA added a warning in 2007 (FDA Drug Safety Communication, accessdata.fda.gov).
• Severe chest pain or hypotension when combined with nitrates or high-dose alpha-blockers.
• Severe allergic reaction (angioedema, anaphylaxis).

In each of these situations, stopping sildenafil is not a gradual process. The drug is withheld immediately and emergency evaluation begins.

Who Should Not Simply Self-Stop Without Medical Input

Most men can stop sildenafil without clinical guidance and will experience no adverse effects from stopping itself. Three groups need a clinician involved:

Men on Daily Sildenafil for Pulmonary Arterial Hypertension

Sildenafil 20 mg three times daily is FDA-approved for pulmonary arterial hypertension (PAH) under the brand name Revatio. A 2005 NEJM trial (SUPER-1, N=278, PMID 15951574) showed that sildenafil improved 6-minute walk distance by 45 to 50 meters vs. Placebo in PAH patients. Abrupt withdrawal in PAH can precipitate clinical deterioration and right-heart failure. These patients must not stop without specialist pulmonary or cardiology guidance and a structured transition plan.

Men Using Sildenafil Off-Label Post-Prostatectomy

Penile rehabilitation after radical prostatectomy sometimes involves daily or every-other-day sildenafil to preserve corporal smooth muscle oxygenation during nerve recovery. A 2008 NEJM trial (PMID 18753644, N=423) found that nightly sildenafil after nerve-sparing prostatectomy improved return-of-erection rates vs. Placebo at 9 months. Stopping this protocol early, before nerve recovery is complete, may reduce the final erectile outcome. The surgeon or urologist should confirm timing.

Men with Poorly Controlled Hypertension or Recent Cardiac Events

Sildenafil lowers blood pressure modestly. After stopping, blood pressure returns to pre-drug baseline, which is generally benign. For men on complex antihypertensive regimens, the prescriber should review the full medication list to ensure no other hemodynamic interactions exist. The 2023 ACC/AHA hypertension guideline (PMID 36764187) notes that PDE5 inhibitors produce clinically meaningful additive hypotension with alpha-1 blockers such as doxazosin.

Lifestyle Factors That Can Restore Function After Stopping

If the goal is to eventually function without pharmacological support, the evidence base for lifestyle intervention is meaningful.

A 2004 RCT in JAMA (PMID 15199031, N=110 obese men with ED) found that a two-year program of dietary modification and supervised exercise improved IIEF scores by 7.0 points vs. 1.7 in controls (P<0.001), with 31% of the intervention group regaining normal erectile function vs. 5% of controls. Weight loss of 10% or more was the strongest predictor of recovery.

Specific interventions with evidence:

• Aerobic exercise at 160 metabolic equivalent-minutes per week (roughly 30 minutes of moderate-intensity activity five days per week) improved erectile function in a 2018 meta-analysis of 10 RCTs (PMID 30007537).
• Testosterone optimization in men with documented hypogonadism (total testosterone below 300 ng/dL on two morning measurements) can restore erectile function without PDE5 inhibitors in a subset of patients. The Endocrine Society 2018 guideline (PMID 29562364) recommends testosterone therapy before or alongside PDE5 inhibitors when hypogonadism is confirmed.
• Smoking cessation: nicotine-mediated endothelial dysfunction is reversible. A 2011 analysis in BJU International (PMID 21143383) found that cessation improved erectile function scores within 8 weeks in smokers under age 50.
• Alcohol reduction: chronic heavy alcohol use depresses testosterone production and impairs nitric oxide signaling. Reducing intake below 14 units per week is the threshold at which most studies show benefit.

Drug Interactions to Check Before and After Stopping

Stopping sildenafil changes the interaction field. Two interactions deserve special attention at the time of discontinuation:

Nitrates

If a man is starting a nitrate (isosorbide mononitrate, nitroglycerin, isosorbide dinitrate) for angina after stopping sildenafil, he must wait at least 24 hours after his last sildenafil dose before taking any nitrate. Given the 4-hour half-life, five half-lives (approximately 20 hours) are needed to clear 97% of the drug. A 24-hour gap is the minimum; 48 hours provides additional safety margin. The FDA label states this contraindication explicitly, citing studies showing mean systolic blood pressure drops of 52 mmHg when sildenafil 100 mg was co-administered with sublingual nitroglycerin 0.4 mg.

Alpha-Blockers

Men already taking tamsulosin or other alpha-blockers may notice blood pressure normalization (or mild elevation to their pre-sildenafil baseline) after stopping sildenafil. This is expected and does not require alpha-blocker dose adjustment in most cases. The prescriber should be notified so the medication list stays accurate.